D. E. Shaw & Co., Inc. Angion Biomedica Corp. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.1 - $2.23 $83,614 - $169,508	-76,013 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.72 - $2.96 $29,456 - $50,692	-17,126 Reduced 18.39%	76,013 $161,000
Q4 2021 Feb 14, 2022	BUY	$2.35 - $9.95 $218,876 - $926,733	93,139 New	93,139 $270,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.